Candriam S.C.A. Has $1.27 Million Stock Holdings in The Clorox Company $CLX

Candriam S.C.A. reduced its position in shares of The Clorox Company (NYSE:CLX) by 19.6% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,581 shares of the company’s stock after selling 2,574 shares during the period. Candriam S.C.A.’s holdings in Clorox were worth $1,271,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in CLX. Impax Asset Management Group plc acquired a new position in shares of Clorox during the 2nd quarter worth $1,285,000. Police & Firemen s Retirement System of New Jersey grew its position in Clorox by 4.0% in the second quarter. Police & Firemen s Retirement System of New Jersey now owns 18,776 shares of the company’s stock valued at $2,254,000 after acquiring an additional 727 shares during the last quarter. denkapparat Operations GmbH acquired a new position in Clorox during the second quarter worth about $228,000. United Asset Strategies Inc. lifted its holdings in shares of Clorox by 20.4% in the second quarter. United Asset Strategies Inc. now owns 41,349 shares of the company’s stock worth $4,965,000 after acquiring an additional 6,993 shares during the last quarter. Finally, Tobam lifted its holdings in shares of Clorox by 16.9% in the second quarter. Tobam now owns 48,784 shares of the company’s stock worth $5,857,000 after acquiring an additional 7,048 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of research firms recently issued reports on CLX. Bank of America lowered their price objective on shares of Clorox from $135.00 to $125.00 and set a “neutral” rating for the company in a research report on Wednesday, October 8th. Jefferies Financial Group reaffirmed a “buy” rating and set a $152.00 target price on shares of Clorox in a research note on Tuesday, November 4th. Zacks Research cut Clorox from a “hold” rating to a “strong sell” rating in a research note on Tuesday, October 28th. Barclays reduced their price objective on Clorox from $112.00 to $108.00 and set an “underweight” rating on the stock in a research report on Tuesday, November 4th. Finally, TD Cowen dropped their target price on Clorox from $120.00 to $117.00 and set a “hold” rating for the company in a research report on Wednesday, October 1st. One investment analyst has rated the stock with a Buy rating, twelve have given a Hold rating and five have assigned a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Reduce” and a consensus price target of $125.69.

Clorox Trading Down 2.4%

Shares of CLX stock opened at $101.23 on Tuesday. The Clorox Company has a 1-year low of $101.11 and a 1-year high of $171.37. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15. The stock has a market cap of $12.35 billion, a price-to-earnings ratio of 15.53, a PEG ratio of 0.92 and a beta of 0.52. The stock has a 50-day moving average of $117.18 and a 200-day moving average of $123.22.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Monday, November 3rd. The company reported $0.85 EPS for the quarter, topping analysts’ consensus estimates of $0.78 by $0.07. The company had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.41 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The firm’s quarterly revenue was down 18.9% on a year-over-year basis. During the same period in the previous year, the firm earned $1.86 earnings per share. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. On average, equities research analysts forecast that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, November 6th. Investors of record on Wednesday, October 22nd were paid a dividend of $1.24 per share. This represents a $4.96 dividend on an annualized basis and a yield of 4.9%. The ex-dividend date of this dividend was Wednesday, October 22nd. Clorox’s dividend payout ratio (DPR) is currently 77.86%.

Insider Transactions at Clorox

In other Clorox news, COO Eric H. Reynolds sold 15,041 shares of the company’s stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the sale, the chief operating officer owned 54,221 shares of the company’s stock, valued at approximately $6,711,475.38. This represents a 21.72% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.63% of the stock is currently owned by insiders.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.